https://www.nature.com/articles/s41419-023-06080-9
Interesting paper on statin intolerance. They find a connection to cannabinoid receptors, and that cannabis is not a solution (my interpretation).
1 Like
JuanDaw
#42
I believe the source paper for Bill Faloon’s article, can be found below:
Click
[
There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness
](https://www.sciencedirect.com/science/article/pii/S2666667722000551)
Michael E. Makover, Michael D. Shapiro, Peter P. Toth
Then click “view pdf”.
1 Like
JuanDaw
#43
Declaration of Competing Interest
Michael Makover: None. Michael Shapiro: Dr Shapiro has participated in the Scientific Advisory Boards for Amgen, Esperion, Novartis, and Novo Nordisk.
Peter P. Toth: Dr. Toth is a member of the speakers bureau for Amarin, Amgen, Esperion, and Novo-Nordisk; he is a consultant to Amarin, Kowa, Merck, Novartis, and Resverlogix.
A_User
#44
Doesn’t matter, only the methodology does.
I just got my prescription for 10 mg daily Ezetimibe. Took the first dose last night. I had a hard time sleeping, but I don’t think it was the Ezetimibe (hopefully). No muscle soreness. Looks like we have a winner.
Unfortunately, it’ll only lower LDL cholesterol by 10-20%. Probably nearer to 10%. However, I’ll take it.
Next trial will be Bempedoic Acid.
2 Likes
Have you already tried very low doses of rosuvastatin like 2.5mg or even 1.25mg daily? In combination with ezetimibe even that should give you LDL reductions of nearly 40%.
1 Like
I’d have to split the pills, and honestly it took me weeks to recover from those statins.
I may try a different statin in the future, bit for now, I am staying away from Rosuvastatin.
LaraPo
#48
It is Ezetimibe! I also have hard time sleeping after I take it. Started taking it in the morning - it helps.
1 Like
Really?!?! The higher energy is a bonus then.
1 Like